Australia offers a favourable ecosystem for clinical research that includes a quality health sector, a strong network of universities, independent medical research institutes, biobanks, CROs and clinical trials networks.
Companies have access to highly skilled researchers and key opinion leaders who undertake clinical trials within internationally-recognised, world class medical research infrastructure.
Most clinical trials in Australia are conducted under the Clinical trials Notification (CTN) scheme which has a reduced cost, time and regulatory burden on clinical trial sponsors for all trials, including first-time-in-human and Phase I trials.
International companies are able to take advantage of Australia’s attractive R&D tax credit scheme to support their local drug development programs. Australia also provides a strong intellectual property protection environment for new drugs and molecules.
For more information on Australia as a destination for your clinical trial portfolio please visit https://www.nhmrc.gov.au/research-policy